Myelodysplastic Syndromes (MDS) & COVID-19: Clinical Experience from the US Epicenter of the Pandemic

Background: The COVID-19 (SARS-CoV-2) pandemic has affected cancer patients (pts) in a myriad of ways, including diagnostic & treatment delays, scarcity of blood products, and most importantly, higher risks of morbidity and mortality from the viral infection itself. Though COVID-19’s effects on...

Descripción completa

Detalles Bibliográficos
Autores principales: Feld, Jonathan, Demakos, Erin P., Odchimar-Reissig, Rosalie, Tremblay, Douglas, Alli, Saudia, Sewah, Darshanie, Navada, Shyamala C., Silverman, Lewis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
637.Myelodysplastic Syndromes-Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330232/
http://dx.doi.org/10.1182/blood-2020-138969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330232/
http://dx.doi.org/10.1182/blood-2020-138969

Ejemplares similares